These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

690 related items for PubMed ID: 16337315

  • 1. Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams.
    Muñoz PM, Estevan M, Marín CM, Jesús De Miguel M, Jesús Grilló M, Barberán M, Irache JM, Blasco JM, Gamazo C.
    Vaccine; 2006 Mar 10; 24(11):1897-905. PubMed ID: 16337315
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of particulate acellular vaccines against Brucella ovis infection in rams.
    Da Costa Martins R, Irache JM, Blasco JM, Muñoz MP, Marín CM, Jesús Grilló M, Jesús De Miguel M, Barberán M, Gamazo C.
    Vaccine; 2010 Apr 09; 28(17):3038-46. PubMed ID: 19887131
    [Abstract] [Full Text] [Related]

  • 3. Comparison of subcutaneous and conjunctival routes of Rev 1 vaccination for the prophylaxis of Brucella ovis infection in rams.
    Marín CM, Barberán M, Jiménez de Bagués MP, Blasco JM.
    Res Vet Sci; 1990 Mar 09; 48(2):209-15. PubMed ID: 2110377
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of bp26 and bp26/omp31 B. melitensis Rev.1 deletion mutants against Brucella ovis in rams.
    Grilló MJ, Marín CM, Barberán M, de Miguel MJ, Laroucau K, Jacques I, Blasco JM.
    Vaccine; 2009 Jan 07; 27(2):187-91. PubMed ID: 19007836
    [Abstract] [Full Text] [Related]

  • 5. Experiments on a sub-unit vaccine encapsulated in microparticles and its efficacy against Brucella melitensis in mice.
    Estevan M, Gamazo C, Grilló MJ, Del Barrio GG, Blasco JM, Irache JM.
    Vaccine; 2006 May 08; 24(19):4179-87. PubMed ID: 16481077
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A, Jacques I, Grilló MJ, Marín CM, Grayon M, Blasco JM, Verger JM.
    Vaccine; 2004 Jul 29; 22(21-22):2827-35. PubMed ID: 15246618
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
    Jacques I, Verger JM, Laroucau K, Grayon M, Vizcaino N, Peix A, Cortade F, Carreras F, Guilloteau LA.
    Vaccine; 2007 Jan 15; 25(5):794-805. PubMed ID: 17070627
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of possible correlates of protective response against Brucella ovis infection in rams immunized with the B. melitensis Rev 1 vaccine.
    Galindo RC, Muñoz PM, de Miguel MJ, Marin CM, Blasco JM, Gortazar C, Kocan KM, de la Fuente J.
    Vaccine; 2009 May 18; 27(23):3039-44. PubMed ID: 19428917
    [Abstract] [Full Text] [Related]

  • 12. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
    Cassataro J, Pasquevich KA, Estein SM, Laplagne DA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH, Goldbaum FA.
    Vaccine; 2007 May 30; 25(22):4437-46. PubMed ID: 17442465
    [Abstract] [Full Text] [Related]

  • 13. The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams.
    Estein SM, Fiorentino MA, Paolicchi FA, Clausse M, Manazza J, Cassataro J, Giambartolomei GH, Coria LM, Zylberman V, Fossati CA, Kjeken R, Goldbaum FA.
    Vaccine; 2009 Nov 12; 27(48):6704-11. PubMed ID: 19748579
    [Abstract] [Full Text] [Related]

  • 14. Residual virulence and immunogenicity of CGV26 and CGV2631 B. melitensis Rev. 1 deletion mutant strains in sheep after subcutaneous or conjunctival vaccination.
    Guilloteau LA, Laroucau K, Olivier M, Grillo MJ, Marin CM, Verger JM, Blasco JM.
    Vaccine; 2006 Apr 24; 24(17):3461-8. PubMed ID: 16519974
    [Abstract] [Full Text] [Related]

  • 15. Use of Brucella canis antigen for detection of ovine serum antibodies against Brucella ovis.
    López G, Ayala SM, Escobar GI, Lucero NE.
    Vet Microbiol; 2005 Feb 25; 105(3-4):181-7. PubMed ID: 15708814
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams.
    Blasco JM, Gamazo C, Winter AJ, Jiménez de Bagüés MP, Marín C, Barberán M, Moriyón I, Alonso-Urmeneta B, Díaz R.
    Vet Immunol Immunopathol; 1993 Aug 25; 37(3-4):257-70. PubMed ID: 8236802
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
    Adone R, Francia M, Ciuchini F.
    Vaccine; 2008 Sep 08; 26(38):4913-7. PubMed ID: 18675869
    [Abstract] [Full Text] [Related]

  • 20. Evaluation in mice of Brucella ovis attenuated mutants for use as live vaccines against B. ovis infection.
    Sancho P, Tejedor C, Sidhu-Muñoz RS, Fernández-Lago L, Vizcaíno N.
    Vet Res; 2014 Jun 04; 45(1):61. PubMed ID: 24898325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.